TRISODIUM 4-((3-(4,5-DICHLORO-6-OXO-6H-PYRIDAZIN-1-YL)PROPIONYL)AMINO)-5-HYDROXY-6-((4-SULFONATOPHENYL)AZO)NAPHTHALENE-2,7-DISULFONATE
UNII XFA6866EH7

Substance Identification & Data

This profile provides standardized clinical and technical data for Trisodium 4-((3-(4,5-dichloro-6-oxo-6h-pyridazin-1-yl)propionyl)amino)-5-hydroxy-6-((4-sulfonatophenyl)azo)naphthalene-2,7-disulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XFA6866EH7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 85958-98-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XFA6866EH7

CAS Registry Number

85958-98-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TRISODIUM 4-((3-(4,5-DICHLORO-6-OXO-6H-PYRIDAZIN-1-YL)PROPIONYL)AMINO)-5-HYDROXY-6-((4-SULFONATOPHENYL)AZO)NAPHTHALENE-2,7-DISULFONATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H14Cl2N5O12S3.3Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AGFMYGHESMMLSS-UHFFFAOYSA-K

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

102269135

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(ccc1N=Nc2c(cc3cc(cc(c3c2O)NC(=O)CCn4c(=O)c(c(cn4)Cl)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trisodium 4-((3-(4,5-dichloro-6-oxo-6h-pyridazin-1-yl)propionyl)amino)-5-hydroxy-6-((4-sulfonatophenyl)azo)naphthalene-2,7-disulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

2,7-NAPHTHALENEDISULFONIC ACID, 5-((3-(4,5-DICHLORO-6-OXO-1(6H)-PYRIDAZINYL)-1-OXOPROPYL)AMINO)-4-HYDROXY-3-((4-SULFOPHENYL)AZO)-,TRISODIUM SALT

SYS

2,7-NAPHTHALENEDISULFONIC ACID, 5-((3-(4,5-DICHLORO-6-OXO-1(6H)-PYRIDAZINYL)-1-OXOPROPYL)AMINO)-4-HYDROXY-3-(2-(4-SULFOPHENYL)DIAZENYL)-,SODIUM SALT (1:3)

SYS

TRISODIUM 4-((3-(4,5-DICHLORO-6-OXO-6H-PYRIDAZIN-1-YL)PROPIONYL)AMINO)-5-HYDROXY-6-((4-SULFONATOPHENYL)AZO)NAPHTHALENE-2,7-DISULFONATE

SYS

TRISODIUM 4-((3-(4,5-DICHLORO-6-OXO-6H-PYRIDAZIN-1-YL)PROPIONYL)AMINO)-5-HYDROXY-6-((4-SULPHONATOPHENYL)AZO)NAPHTHALENE-2,7-DISULPHONATE

SYS